Gene therapy using Aβ variants for amyloid reduction-Reference-Cited by-同舟云学术

Gene therapy using Aβ variants for amyloid reduction

Published:2021-07 Issue:7 Volume:29 Page:2294-2307
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Park Kyung-Won,Wood Caleb A.,Li Jun,Taylor Bethany C.,Oh SaeWoong,Young Nicolas L.,Jankowsky Joanna L.

Funder

Robert A and Renee E Belfer Family Foundation

NIH

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference68 articles.

1. Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies. Globe Newswire, October 22, 2019. https://www.globenewswire.com/news-release/2019/10/22/1933045/0/en/Biogen-Plans-Regulatory-Filing-for-Aducanumab-in-Alzheimer-s-Disease-Based-on-New-Analysis-of-Larger-Dataset-from-Phase-3-Studies.html.

2. FDA Advisory Committee Throws Cold Water on Aducanumab Filing. Alzforum, Networking for a Cure, November 6, 2020. https://www.alzforum.org/news/community-news/fda-advisory-committee-throws-cold-water-aducanumab-filing.

3. Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design;Mishra;ChemMedChem,2015

4. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer’s therapy;Soto;Nat. Med.,1998

5. Short Peptides as Inhibitors of Amyloid Aggregation;Neddenriep;Open Biotechnol. J.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simple improvements in vector design afford substantial gains in AAV delivery of aggregation-slowing Aβ variants;Molecular Therapy - Nucleic Acids;2024-12

2. The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment;Cells;2023-11-21

3. The TMEM106B T186S coding variant increases neurite arborization and synaptic density in primary hippocampal neurons;Frontiers in Neuroscience;2023-10-13

4. Activity disruption causes degeneration of entorhinal neurons in a mouse model of Alzheimer’s circuit dysfunction;eLife;2022-12-05

5. Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers;Expert Review of Neurotherapeutics;2022-04-03